Swiss National Bank grew its position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 1.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 171,700 shares of the company’s stock after buying an additional 1,800 shares during the quarter. Swiss National Bank’s holdings in HealthEquity were worth $16,475,000 as of its most recent filing with the SEC.
A number of other large investors also recently bought and sold shares of HQY. GSA Capital Partners LLP purchased a new position in HealthEquity during the 3rd quarter worth $638,000. KBC Group NV raised its position in HealthEquity by 16.1% during the 3rd quarter. KBC Group NV now owns 2,463 shares of the company’s stock worth $202,000 after buying an additional 341 shares during the last quarter. Natixis Advisors LLC raised its position in HealthEquity by 29.8% during the 3rd quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after buying an additional 48,009 shares during the last quarter. Mutual of America Capital Management LLC increased its holdings in shares of HealthEquity by 0.7% in the 3rd quarter. Mutual of America Capital Management LLC now owns 97,718 shares of the company’s stock valued at $7,998,000 after purchasing an additional 648 shares in the last quarter. Finally, Thrivent Financial for Lutherans increased its holdings in shares of HealthEquity by 33.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock valued at $24,033,000 after purchasing an additional 73,404 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.
Insiders Place Their Bets
In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is owned by corporate insiders.
Analyst Ratings Changes
View Our Latest Stock Analysis on HQY
HealthEquity Price Performance
HealthEquity stock opened at $101.67 on Wednesday. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The stock has a market capitalization of $8.81 billion, a P/E ratio of 93.28, a P/E/G ratio of 1.60 and a beta of 0.62. The firm’s 50-day moving average is $105.82 and its two-hundred day moving average is $95.67. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
- Five stocks we like better than HealthEquity
- High Flyers: 3 Natural Gas Stocks for March 2022
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What Are Growth Stocks and Investing in Them
- 3 Must-Own Stocks to Build Wealth This Decade
- What is the Nasdaq? Complete Overview with History
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.